Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pyrazinamide
Drug ID BADD_D01880
Description A pyrazine that is used therapeutically as an antitubercular agent.
Indications and Usage For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
Marketing Status Prescription
ATC Code J04AK01
DrugBank ID DB00339
KEGG ID D00144
MeSH ID D011718
PubChem ID 1046
TTD Drug ID D0XF8W
NDC Product Code 70518-2534; 66639-165; 70954-484; 61748-012; 33342-447; 50090-0520; 0904-6696; 11712-815; 49452-6135; 50090-0521; 71052-311
Synonyms Pyrazinamide | Tisamid
Chemical Information
Molecular Formula C5H5N3O
CAS Registry Number 98-96-4
SMILES C1=CN=C(C=N1)C(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Peptic ulcer07.04.07.001--Not Available
Photosensitivity reaction23.03.09.003--
Platelet count decreased13.01.04.0010.004591%
Pneumonia22.07.01.003; 11.01.09.0030.006887%Not Available
Polyuria20.02.03.0020.006887%Not Available
Porphyria14.14.01.001; 03.08.01.001--Not Available
Pruritus23.03.12.0010.006887%
Pulmonary tuberculosis11.04.01.003; 22.07.06.0020.001796%Not Available
Pyrexia08.05.02.0030.011478%
Rash23.03.13.0010.011478%Not Available
Rash maculo-papular23.03.13.004--
Rhabdomyolysis15.05.05.0020.004591%
Sense of oppression08.01.09.0200.004591%Not Available
Sideroblastic anaemia01.03.02.009--Not Available
Splenomegaly01.09.02.001--Not Available
Syncope24.06.02.012; 02.01.02.008; 17.02.04.0080.004591%
Thrombocytopenia01.08.01.0020.006887%Not Available
Tuberculosis11.04.01.0060.006887%Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.0030.013773%
Weight decreased13.15.01.0050.006887%
Tubulointerstitial nephritis20.05.02.0020.004591%Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Red blood cell vacuolisation01.07.02.007--Not Available
Hepatic enzyme increased13.03.01.0190.027546%Not Available
Porphyrin metabolism disorder14.14.01.006; 09.01.10.004; 03.08.01.006--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Ill-defined disorder08.01.03.049--Not Available
Atypical mycobacterial infection11.04.02.0020.004591%Not Available
Drug intolerance08.06.01.0130.004591%Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages